Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Peltekian

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirinV G Bain, S S Lee, K Peltekian, et al.
Gut|May 20, 2006
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapyM Sherman, E M Yoshida, M Deschenes, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 15, 2007
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trialA Chatterjee, M G Swain, S S Lee, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis BJ P Villeneuve, L D Condreay, B Willems, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 26, 2009
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapyE M Yoshida, M Sherman, V G Bain, et al.
IEEE Transactions on Medical Imaging|June 17, 2026
REN: Anatomically-Informed Mixture-of-Experts for Interstitial Lung Disease DiagnosisAlec K Peltekian, Halil Ertugrul Aktas, Gorkem Durak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Omicron detection with large language models and YouTube audio dataJames T Anibal, Adam J Landa, Nguyen T T Hang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Developing and externally validating machine learning models to forecast short-term risk of ventilator-associated pneumoniaAlec K Peltekian, Wan-Ting Liao, Vijeeth Guggilla, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic SclerosisAlec K Peltekian, Kevin M Grudzinski, Bradford C Bemiss, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirinV G Bain, S S Lee, K Peltekian, et al.
Gut|May 20, 2006
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapyM Sherman, E M Yoshida, M Deschenes, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 15, 2007
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trialA Chatterjee, M G Swain, S S Lee, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis BJ P Villeneuve, L D Condreay, B Willems, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 26, 2009
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapyE M Yoshida, M Sherman, V G Bain, et al.
IEEE Transactions on Medical Imaging|June 17, 2026
REN: Anatomically-Informed Mixture-of-Experts for Interstitial Lung Disease DiagnosisAlec K Peltekian, Halil Ertugrul Aktas, Gorkem Durak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Omicron detection with large language models and YouTube audio dataJames T Anibal, Adam J Landa, Nguyen T T Hang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Developing and externally validating machine learning models to forecast short-term risk of ventilator-associated pneumoniaAlec K Peltekian, Wan-Ting Liao, Vijeeth Guggilla, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic SclerosisAlec K Peltekian, Kevin M Grudzinski, Bradford C Bemiss, et al.
Pageof 2